# Korsana (KRSA) — News

KRSA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/krsa/news

## Recent headlines

- [Korsana Biosciences, Inc.: Wedbush initiates coverage with outperform rating; target price $44](https://www.ainvest.com/news/korsana-biosciences-wedbush-initiates-coverage-outperform-rating-target-price-44-2610) — AInvest Wire, Oct 5, 2026
  Wedbush Securities has initiated coverage on Korsana Biosciences, Inc. (KRSA) with an "outperform" rating and a target price of $44 per share. This move comes as the biotechnology firm prepares to release its next quarterly earnings report on November 10, 2026. Korsana has reported consistent net…
- [Korsana Biosciences, Inc.: Stifel initiates coverage with buy rating; target price $43](https://www.ainvest.com/news/korsana-biosciences-stifel-initiates-coverage-buy-rating-target-price-43-2609) — AInvest Wire, Sep 14, 2026
  Stifel has initiated coverage of Korsana Biosciences, Inc. (NASDAQ: KORS) with a "buy" rating and a target price of $43 per share. The firm cited the company’s progress in its clinical pipeline and strategic positioning in the biotechnology sector as key factors in its recommendation. Korsana…
- [Korsana Biosciences, Inc.: TD Cowen initiates coverage with buy rating](https://www.ainvest.com/news/korsana-biosciences-td-cowen-initiates-coverage-buy-rating-2609) — AInvest Wire, Sep 14, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).